ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Erasca Inc

Erasca Inc (ERAS)

2.70
0.00
(0.00%)
Closed 25 November 8:00AM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.70
Bid
2.65
Offer
2.90
Volume
-
0.00 Day's Range 0.00
1.51 52 Week Range 3.45
Market Cap
Previous Close
2.70
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,920,701
Shares Outstanding
282,727,282
Dividend Yield
-
PE Ratio
-6.10
Earnings Per Share (EPS)
-0.44
Revenue
-
Net Profit
-125.04M

About Erasca Inc

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was US$2.70. Over the last year, Erasca shares have traded in a share price range of US$ 1.51 to US$ 3.45.

Erasca currently has 282,727,282 shares in issue. The market capitalisation of Erasca is US$763.36 million. Erasca has a price to earnings ratio (PE ratio) of -6.10.

ERAS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-4.255319148942.822.942.5113339112.68565007CS
40.041.50375939852.663.3052.4417017492.85633987CS
12-0.15-5.263157894742.853.3052.4119207012.82563973CS
260.3514.89361702132.353.451.9621152322.70370584CS
520.4419.46902654872.263.451.5116478042.46541039CS
156-15.44-85.115766262418.1418.341.5110314514.07011506CS
260-13.2-83.018867924515.924.471.519645534.76386877CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SKKSKK Holdings Limited
US$ 2.055
(86.82%)
21.66M
WCTWellchange Holdings Company Limited
US$ 2.21
(76.80%)
26.62M
SJWSJW Group
US$ 87.99
(58.97%)
145
NSTSNSTS Bancorp Inc
US$ 17.72
(58.36%)
10
IMOSChipMOS Technologies Inc
US$ 27.99
(44.28%)
26
AALAmerican Airlines Group Inc
US$ 14.38
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 67.50
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.30
(0.00%)
0
AACGATA Creativity Global
US$ 1.02
(0.00%)
0
ELABElevai Labs Inc
US$ 0.01855
(-8.17%)
42.91M
VRPXVirpax Pharmaceuticals Inc
US$ 0.802
(36.00%)
38.87M
WCTWellchange Holdings Company Limited
US$ 2.21
(76.80%)
26.62M
SKKSKK Holdings Limited
US$ 2.055
(86.82%)
21.66M
LIFWMSP Recovery Inc
US$ 1.78
(20.27%)
18.58M

Your Recent History

Delayed Upgrade Clock